Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease
Open Access
- 2 July 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Inflammation
- Vol. 12 (1), 41
- https://doi.org/10.1186/s12950-015-0086-z
Abstract
Behçet’s disease (BD) is a systemic inflammatory disease with manifestations including recurrent oral and genital ulcerations, and vasculitis involving the skin, mucosa, joints, eyes, veins, arteries, nervous and gastrointestinal systems. BD is seen as a disease at the crossroad between autoimmune and autoinflammatory syndromes, possibly triggered by an aberrant response to infectious stimuli. The relevance of Gram negative bacteria-mediated oral inflammation with the increased expression of NACHT, LRR, and PYD domains-containing protein 3 (NLRP3), leading to systemic inflammation, prompted us to investigate the expression of NLRP3 inflammasome components and its link with IL-1β hypersecretion. When peripheral blood mononuclear cells (PBMCs) from 15 active, 15 stable BD patients and 15 healthy volunteers were stimulated, the basal and LPS-induced expressions of NLRP3 inflammasome components were significantly increased at both mRNA and protein levels in BD patients compared to healthy controls. Also, increased expression of NLRP3 and ASC was observed in 25 BD skin lesions compared to 25 erythema nodosum patients. Compatible with this, secretion of IL-1β by PBMCs stimulated with LPS alone or LPS plus ATP was increased in BD compared to healthy controls, which was suppressed by caspase-1 inhibitor. Our findings suggest the possible link between increased IL-1β secretion and increased expression of NLRP3 inflammasome components in BD patients with skin manifestations.Keywords
This publication has 16 references indexed in Scilit:
- Of inflammasomes and pathogens – sensing of microbes by the inflammasomeEMBO Molecular Medicine, 2013
- New insights into the pathogenesis of Behçet's diseaseAutoimmunity Reviews, 2012
- TLR‐induced NF‐κB activation regulates NLRP3 expression in murine macrophagesFEBS Letters, 2012
- Targeting IL-1β in disease; the expanding role of NLRP3 inflammasomeEuropean Journal of Internal Medicine, 2010
- IL-1β Processing in Host Defense: Beyond the InflammasomesPLoS Pathogens, 2010
- Thalidomide Inhibits Activation of Caspase-1The Journal of Immunology, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's diseaseRheumatology, 2008
- Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?Rheumatology, 2006
- The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trialArthritis & Rheumatism, 1996